Minapharm Pharmaceuticals

Minapharm Pharmaceuticals company information, Employees & Contact Information

Minapharm Pharmaceuticals is a leading pharmaceutical company in Egypt and the Middle East and the premier biopharmaceutical company in Africa with over 20 years of experience in cellular and bioprocess engineering. Headquartered in Cairo, Minapharm commercializes over 100 life-saving and life-enhancing products ranging from small molecules to complex genetically-engineered proteins, with an impressive immunotherapy pipeline. Together with its wholly owned Berlin-based subsidiary, ProBioGen, Minapharm has established an integrated business model making it to-date the only gene-to-market biopharmaceutical company in the region.

Company Details

Employees
966
Founded
-
Address
El Bardissi Street 2t Takseem Asmaa Fahmy, Ard El Golf, Heliopolis, Cairo,egypt
Phone
+202 2414 3170
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Cairo
Looking for a particular Minapharm Pharmaceuticals employee's phone or email?

Minapharm Pharmaceuticals Questions

News

IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa - ACCESS Newswire

IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa ACCESS Newswire

Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion - Dailynewsegypt

Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion Dailynewsegypt

Minapharm’s majority shareholder Triquera raises capital through minority stake investment from Admaius Capital Partners - ZAWYA

Minapharm’s majority shareholder Triquera raises capital through minority stake investment from Admaius Capital Partners ZAWYA

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa - PR Newswire

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa PR Newswire

IAVI, Minapharm, & ProBioGen Launch Vaccine & Biologics Manufacturing Partnership in Africa - Contract Pharma

IAVI, Minapharm, & ProBioGen Launch Vaccine & Biologics Manufacturing Partnership in Africa Contract Pharma

SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries - African Business

SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries African Business

African Development Bank approves EUR 15 Million loan to boost Biosimilars’ Development and Production in Egypt - African Development Bank Group

African Development Bank approves EUR 15 Million loan to boost Biosimilars’ Development and Production in Egypt African Development Bank Group

Sanofi taps local drugmaker Minapharm to crank out popular blood thinner Clexane in Egypt - Fierce Pharma

Sanofi taps local drugmaker Minapharm to crank out popular blood thinner Clexane in Egypt Fierce Pharma

Egypt: Minapharm majority shareholder Triquera gains investment from Admaius Capital Partners - Investors in Healthcare

Egypt: Minapharm majority shareholder Triquera gains investment from Admaius Capital Partners Investors in Healthcare

ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company - PR Newswire

ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company PR Newswire

Enterprise — Essential business, finance and policy news from the Arab world - enterprise.news

Enterprise — Essential business, finance and policy news from the Arab world enterprise.news

Sanofi, Minapharm Ink Deal for Localizing the Manufacture of Clexane - Contract Pharma

Sanofi, Minapharm Ink Deal for Localizing the Manufacture of Clexane Contract Pharma

Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane® - PR Newswire

Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane® PR Newswire

Enterprise — Essential business, finance and policy news from the Arab world - enterprise.news

Enterprise — Essential business, finance and policy news from the Arab world enterprise.news

Potential investor to start due diligence on Minapharm Pharmaceuticals - Dailynewsegypt

Potential investor to start due diligence on Minapharm Pharmaceuticals Dailynewsegypt

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant